High testosterone levels raise heart disease risk in older women

Article

Women older than age 65 years who are overweight and have elevated levels of testosterone are at increased risk for developing coronary heart disease, insulin resistance, and other manifestations of metabolic syndrome.

Women older than age 65 years who are overweight and have elevated levels of testosterone are at increased risk for developing coronary heart disease, insulin resistance, and other manifestations of metabolic syndrome.

A multicenter study of 344 women between 65 and 98 years of age enrolled in the Cardiovascular Health Study measured levels of total and free testosterone by equilibrium dialysis. Cross-sectional analyses examined associations among total and free testosterone and metabolic syndrome, insulin resistance, and coronary heart disease.

Researchers found a stepwise increase in insulin resistance with increased levels of total (P=.003) and free (P=.02) testosterone and a corresponding decrease in Quantitative Insulin Sensitivity Check Index (P<.001 and P=.002, respectively). Adjusted models also found strong associations between high levels of both total and free testosterone and abdominal obesity and high fasting glucose. Finally, women in the top quartile of total testosterone levels had 3-fold greater odds than women in the bottom quartile of developing metabolic syndrome and 3-fold greater odds than those in the second quartile of developing coronary heart disease.

Patel SM, Ratcliffe SJ, Reilly MP, et al. J Clin Endocrinol Metab. E-pub October 21, 2009. doi:10.1210/jc.2009-0740.

Recent Videos
HPV self-collection: Benefits, limitations, and future implications | Image Credit: forhers.com
Improving pediatric HPV vaccination rates: Early initiation and addressing disparities | Image Credit: blog.nemours.org.
New cervical cancer screening guidelines: What practitioners needs to know | Image Credit: forhers.com
COVID-19 Therapy Roundtable: Focusing on inpatient care
COVID-19 Therapy Roundtable: Defining the virus today and treatment options
How fezolinetant advances non-hormonal treatment of hot flashes | Image Credit: medschool.cuanschutz.edu
Contraceptive access challenges for college students in contraception deserts | Image Credit: linkedin.com.
Kameelah Phillips, MD, FACOG, NCMP, is featured in this series.
© 2024 MJH Life Sciences

All rights reserved.